argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
840.50
-7.22 (-0.85%)
At close: Jan 30, 2026, 4:00 PM EST
843.50
+3.00 (0.36%)
Pre-market: Feb 2, 2026, 5:46 AM EST
argenx SE Market Cap
argenx SE has a market cap or net worth of $51.17 billion as of February 2, 2026. Its market cap has increased by 28.65% in one year.
Market Cap
51.17B
Enterprise Value
47.24B
1-Year Change
28.65%
Ranking
Category
Stock Price
$840.50
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $51.17B, an increase of 8,180.45%. That is a compound annual growth rate of 66.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 51.30B | -0.05% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 119.22B |
| Regeneron Pharmaceuticals | 76.07B |
| Alnylam Pharmaceuticals | 44.66B |
| BeOne Medicines AG | 37.67B |
| Insmed | 33.46B |
| BioNTech SE | 28.54B |
| Royalty Pharma | 24.06B |
| Genmab | 19.81B |